Targeting Regulatory RNA to Upregulate Gene Expression to Treat Rare Diseases

Ann Barbier, chief medical officer of Camp4 Therapeutics, discusses Dravet syndrome, the company’s platform technology to develop therapies that can upregulate gene expression, and the potential to apply its approach to a broad range of conditions.